Answers are grounded in this paper and cite their sources.
By modulating the ERK/EGR3 pathway, IL-6 stimulated Cyr61 production and in turn increased invasiveness of FLS. Our data suggest that Cyr61 might be a potential target to prevent the progression of joint damage in RA.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: